Jewell Martin, MA, MBA, PMP, RAC

Director for US Regulatory Policy
BioMarin Pharmaceutical, Inc.

Jewell Martin serves as the Director for US Policy on the Global R&D and Regulatory Policy team at BioMarin Pharmaceutical Inc. Prior to joining BioMarin in 2020, Jewell spent 10 years at the US Food and Drug Administration (FDA), where she served in multiple roles including as the Executive Operations Staff Lead in the Office of New Drugs, in the Center for Drug Evaluation and Research (CDER).

Jewell received her MA in Medical Sciences from Boston University and MBA from Howard University in Washington, DC. Additionally, she received certifications including the Project Management Professional (PMP) and Regulatory Affairs Certification (RAC).

Presentation(s):

• Maximizing Opportunities to Engage With the FDA

  Tuesday, September 17, 2024
  8:30 AM – 4:00 PM PDT

• Quantifying Patient Burden in Protocol Design to Reduce Complexity and Drive Patient-Centricity

  Wednesday, September 18, 2024
  2:15 PM – 3:15 PM PDT

• Lessons Learned Since the Implementation of FDA’s Diversity Plans & an Assessment of the 2024 Diversity Action Plans FDA Guidance

  Thursday, September 19, 2024
  3:15 PM – 4:15 PM PDT

• Health Authority Forum: CDER - FDA's Center for Drug Evaluation and Research

  Thursday, September 19, 2024
  4:30 PM – 5:30 PM PDT